Toll Free: 1-888-928-9744
Published: Apr, 2017 | Pages:
146 | Publisher: QYResearch
Industry: Manufacturing | Report Format: Electronic (PDF)
This report studies the Contract Pharmaceutical Manufacturing on United States and global market, focuses on the top players in US market and also the market status and outlook by type and application. Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Contract Pharmaceutical Manufacturing in these regions, from 2012 to 2022 (forecast), covering North America Europe Asia-Pacific South America Middle East and Africa The major players in United States Contract Pharmaceutical Manufacturing market include Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie?, Nipro Corp, Vetter, Sopharma, DPT Laboratories, Recipharm The On the basis of product, the Contract Pharmaceutical Manufacturing market is primarily split into Active Pharmaceutical Ingredients (API)? Finished Dosage Formulations (FDF) Others On the basis on the end users/applications, this report covers Big Pharma Specialty/Midsize Companies Pharmaceutical Generics Others
Table of Contents 2017-2022 Contract Pharmaceutical Manufacturing Report on United States and Global Market, Status and Forecast, by Players, Types and Applications 1 Methodology and Data Source 1.1 Methodology/Research Approach 1.1.1 Research Programs/Design 1.1.2 Market Size Estimation 1.1.3 Market Breakdown and Data Triangulation 1.2 Data Source 2.1.1 Secondary Sources 2.1.2 Primary Sources 1.3 Disclaimer 2 Contract Pharmaceutical Manufacturing Market Overview 2.1 Contract Pharmaceutical Manufacturing Product Overview 2.2 Contract Pharmaceutical Manufacturing Segment by Types (Product Category) 2.2.1 United States Contract Pharmaceutical Manufacturing Sales and Growth (%) Comparison by Types (Product Category) (2012-2022) 2.2.2 United States Contract Pharmaceutical Manufacturing Sales Market Share (%) by Types (Product Category) in 2016 2.2.3 Active Pharmaceutical Ingredients (API)? 2.2.4 Finished Dosage Formulations (FDF) 2.2.5 Others 2.3 United States Contract Pharmaceutical Manufacturing Segment by Applications 2.3.1 United States Contract Pharmaceutical Manufacturing Sales (K Sets) Comparison by Applications (2012-2022) 2.3.2 Big Pharma 2.3.3 Specialty/Midsize Companies 2.3.4 Pharmaceutical Generics 2.3.5 Others 2.4 Global Contract Pharmaceutical Manufacturing Market Comparison by Regions (2012-2022) 2.4.1 Global Contract Pharmaceutical Manufacturing Market Size and Growth (%) Comparison by Regions (2012-2022) 2.4.2 North America Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022) 2.4.3 Asia-Pacific Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022) 2.4.4 Europe Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022) 2.4.5 South America Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022) 2.4.6 Middle East and Africa Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022) 2.5 Global Contract Pharmaceutical Manufacturing Market Size (2012-2022) 2.5.1 Global Contract Pharmaceutical Manufacturing Revenue (Million USD) Status and Outlook (2012-2022) 2.5.2 Global Contract Pharmaceutical Manufacturing Sales (K Sets) Status and Outlook (2012-2022) 2.6 United States Contract Pharmaceutical Manufacturing Market Size (2012-2022) 2.6.1 United States Contract Pharmaceutical Manufacturing Revenue (Million USD) Status and Outlook (2012-2022) 2.6.2 United States Contract Pharmaceutical Manufacturing Sales (K Sets) Status and Outlook (2012-2022) 3 United States Contract Pharmaceutical Manufacturing Market Competition by Players/Manufacturers 3.1 United States Contract Pharmaceutical Manufacturing Sales (K Sets) and Share by Players (2012-2017) 3.2 United States Contract Pharmaceutical Manufacturing Revenue (Million USD) and Share by Players (2012-2017) 3.3 United States Contract Pharmaceutical Manufacturing Average Price (USD/Set) by Players (2012-2017) 3.4 Players Contract Pharmaceutical Manufacturing Manufacturing Base Distribution, Sales Area, Product Types 3.5 Contract Pharmaceutical Manufacturing Market Competitive Situation and Trends 3.5.1 Contract Pharmaceutical Manufacturing Market Concentration Rate 3.5.2 Contract Pharmaceutical Manufacturing Market Share (%) of Top 3 and Top 5 Players 3.5.3 Mergers & Acquisitions, Expansion 4 Global Contract Pharmaceutical Manufacturing Market Comparison by Regions 4.2 Global Contract Pharmaceutical Manufacturing Sales (K Sets) and Market Share (%) by Regions (2012-2017) 4.3 Global Contract Pharmaceutical Manufacturing Revenue (Million USD) and Market Share (%) by Regions (2012-2017) 4.3 Global Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) 4.5 North America Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) 4.6 Europe Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) 4.7 Asia-Pacific Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) 4.8 South America Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (2012-2017) 4.9 Middle East and Africa Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) 5 United States Contract Pharmaceutical Manufacturing Sales, Revenue, Price Trend by Types 5.1 United States Contract Pharmaceutical Manufacturing Sales (K Sets) and Market Share (%) by Types (2012-2017) 5.2 United States Contract Pharmaceutical Manufacturing Revenue and Market Share (%) by Types (2012-2017) 5.3 United States Contract Pharmaceutical Manufacturing Price (USD/Set) by Type (2012-2017) 5.4 Active Pharmaceutical Ingredients (API)? 5.4.1 United States Active Pharmaceutical Ingredients (API)? Sales (K Sets) and Growth Rate (%) (2012-2017) 5.4.2 United States Active Pharmaceutical Ingredients (API)? Revenue (Million USD) and Growth Rate (%) (2012-2017) 5.5 Finished Dosage Formulations (FDF) 5.5.1 United States Finished Dosage Formulations (FDF) Sales (K Sets) and Growth Rate (%) (2012-2017) 5.5.2 United States Finished Dosage Formulations (FDF) Revenue (Million USD) and Growth Rate (%) (2012-2017) 5.6 Others 6 United States Contract Pharmaceutical Manufacturing Market Analysis by Applications 6.1 United States Contract Pharmaceutical Manufacturing Sales (K Sets) and Market Share (%) by Applications (2012-2017) 6.2 United States Contract Pharmaceutical Manufacturing Sales Growth Rate (%) by Applications (2012-2017) 6.3 Big Pharma Sales Growth Rate 6.4 Specialty/Midsize Companies Sales Growth Rate 6.5 Pharmaceutical Generics Sales Growth Rate 6.6 Others 7 United States Contract Pharmaceutical Manufacturing Players Profiles/Analysis 7.1 Catalent 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Catalent Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.1.4 Main Business/Business Overview 7.2 DPx 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 DPx Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.2.4 Main Business/Business Overview 7.3 Lonza 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Lonza Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.3.4 Main Business/Business Overview 7.4 Piramal Healthcare 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.4.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.4.2.1 Product A 7.4.2.2 Product A 7.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.4.4 Main Business/Business Overview 7.5 Aenova 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.5.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 Aenova Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.5.4 Main Business/Business Overview 7.6 Jubilant 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.6.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.6.2.1 Product A 7.6.2.2 Product B 7.6.3 Jubilant Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.6.4 Main Business/Business Overview 7.7 Famar 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.7.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.7.2.1 Product A 7.7.2.2 Product B 7.7.3 Famar Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.7.4 Main Business/Business Overview 7.8 Boehringer Ingelheim 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.8.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.8.2.1 Product A 7.8.2.2 Product B 7.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.8.4 Main Business/Business Overview 7.9 Fareva Holding 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.9.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.9.2.1 Product A 7.9.2.2 Product B 7.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.9.4 Main Business/Business Overview 7.10 AbbVie? 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.10.2 Contract Pharmaceutical Manufacturing Product Category, End Uses and Specification 7.10.2.1 Type A 7.10.2.2 Type B 7.10.3 AbbVie? Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) 7.10.4 Main Business/Business Overview 7.11 Nipro Corp 7.12 Vetter 7.13 Sopharma 7.14 DPT Laboratories 7.15 Recipharm 8 Contract Pharmaceutical Manufacturing Manufacturing Cost, Industrial Chain and Downstream Buyers 8.1 Contract Pharmaceutical Manufacturing Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.1.4 Market Concentration Rate of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.3 Contract Pharmaceutical Manufacturing Industrial Chain Analysis 8.4 Downstream Buyers in United States 9 Marketing Strategy Analysis, Distributors/Traders and Market Effect Factors 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Distributors in Untied States 9.3 Market Effect Factors Analysis 9.3.1 Economic/Political Environmental Change 9.3.2 Downstream Demand Change 9.3.3 Technology Progress in Related Industry 9.3.4 Substitutes Threat 10 United States and Global Contract Pharmaceutical Manufacturing Market Forecast 10.1 Global Contract Pharmaceutical Manufacturing Sales, Revenue Forecast (2017-2022) 10.1.1 Global Contract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Forecast (2017-2022) 10.1.2 Global Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022) 10.2 United States Contract Pharmaceutical Manufacturing Market Forecast 10.1.1 United States Contract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Forecast (2017-2022) 10.2.2 United States Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022) 10.3 Global Contract Pharmaceutical Manufacturing Forecast by Regions 10.3.1 North America Contract Pharmaceutical Manufacturing Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022) 10.3.2 Europe Contract Pharmaceutical Manufacturing Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022) 10.3.3 Asia-Pacific Contract Pharmaceutical Manufacturing Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022) 10.3.4 South America Contract Pharmaceutical Manufacturing Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022) 10.3.5 Middle East and Africa Contract Pharmaceutical Manufacturing Sales (K Sets) and Revenue (Million USD) Forecast (2017-2022) 10.4 United Status Contract Pharmaceutical Manufacturing Sales, Revenue Forecast by Type (2017-2022) 10.5 United Status Contract Pharmaceutical Manufacturing Sales (K Sets) Forecast by Application (2017-2022) 11 Research Findings and Conclusion
List of Tables and Figures Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources Figure Product Picture of Contract Pharmaceutical Manufacturing Table United States Contract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022) Figure United States Contract Pharmaceutical Manufacturing Sales Market Share (%) by Types (Product Category) in 2016 Figure Product Picture of Active Pharmaceutical Ingredients (API)? Table Major Players of Active Pharmaceutical Ingredients (API)? Figure Product Picture of Finished Dosage Formulations (FDF) Table Major Players of Finished Dosage Formulations (FDF) Figure Product Picture of Others Table Major Players of Others Table United States Contract Pharmaceutical Manufacturing Sales (K Sets) Comparison by Applications (2012-2022) Figure United States Contract Pharmaceutical Manufacturing Sales Market Share (%) by Applications in 2016 Figure Big Pharma Examples Figure Specialty/Midsize Companies Examples Figure Pharmaceutical Generics Examples Figure Other Examples Table Global Contract Pharmaceutical Manufacturing Market Size Comparison and Growth (%) by Regions (2012-2022) Figure North America Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure Asia-Pacific Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure Europe Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure South America Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure Middle East and Africa Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure Global Contract Pharmaceutical Manufacturing Revenue (Million USD) Status and Outlook (2012-2022) Figure Global Contract Pharmaceutical Manufacturing Sales (K Sets) Status and Outlook (2012-2022) Figure United States Contract Pharmaceutical Manufacturing Revenue (Million USD) Status and Outlook (2012-2022) Figure United States Contract Pharmaceutical Manufacturing Sales (K Sets) Status and Outlook (2012-2022) Table United States Contract Pharmaceutical Manufacturing Sales (K Sets) of Key Players (2012-2017) Table United States Contract Pharmaceutical Manufacturing Sales Share (%) by Players (2012-2017) Figure 2016 United States Contract Pharmaceutical Manufacturing Sales Share (%) by Players Figure 2017 United States Contract Pharmaceutical Manufacturing Sales Share (%) by Players Table United States Contract Pharmaceutical Manufacturing Revenue (Million USD) by Players (2012-2017) Table United States Contract Pharmaceutical Manufacturing Revenue Share (%) by Players (2012-2017) Table 2016 United States Contract Pharmaceutical Manufacturing Revenue Share (%) by Players Table 2016 United States Contract Pharmaceutical Manufacturing Revenue Share (%) by Players Table United States Market Contract Pharmaceutical Manufacturing Average Price (USD/Set) of Key Players (2012-2017) Figure United States Market Contract Pharmaceutical Manufacturing Average Price (USD/Set) of Key Players in 2016 Table United States Contract Pharmaceutical Manufacturing Top Players Manufacturing Base Distribution and Sales Area Table United States Contract Pharmaceutical Manufacturing Top Players Product Category Figure Contract Pharmaceutical Manufacturing Market Share (%) of Top 3 Players Figure Contract Pharmaceutical Manufacturing Market Share (%) of Top 5 Players Table Global Contract Pharmaceutical Manufacturing Sales (K Sets) by Regions (2012-2017) Figure Global Contract Pharmaceutical Manufacturing Sales Market Share (%) by Regions (2012-2017) Figure Global Contract Pharmaceutical Manufacturing Sales Market Share (%) by Regions (2012-2017) Figure 2016 Global Contract Pharmaceutical Manufacturing Sales Market Share (%) by Regions Table Global Contract Pharmaceutical Manufacturing Revenue (Million USD) by Regions (2012-2017) Table Global Contract Pharmaceutical Manufacturing Revenue Market Share (%) by Regions (2012-2017) Figure Global Contract Pharmaceutical Manufacturing Revenue Market Share (%) by Regions (2012-2017) Figure 2016 Global Contract Pharmaceutical Manufacturing Revenue Market Share (%) by Regions Table Global Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) Table North America Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) Table Europe Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) Table Asia-Pacific Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) Table South America Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) Table Middle East and Africa Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set) and Gross Margin (%) (2012-2017) Table United States Contract Pharmaceutical Manufacturing Sales (K Sets) by Types (2012-2017) Table United States Contract Pharmaceutical Manufacturing Sales Share (%) by Types (2012-2017) Figure United States Sales Contract Pharmaceutical Manufacturing Market Share (%) by Types (2012-2017) Figure United States Sales Contract Pharmaceutical Manufacturing Market Share (%) by Types in 2016 Table United States Contract Pharmaceutical Manufacturing Revenue (Million USD) by Types (2012-2017) Table United States Contract Pharmaceutical Manufacturing Revenue Share (%) by Types (2012-2017) Figure United States Contract Pharmaceutical Manufacturing Revenue Share (%)by Types (2012-2017) Figure 2016 United States Contract Pharmaceutical Manufacturing Revenue Market Share (%) by Types Table United States Contract Pharmaceutical Manufacturing Price (USD/Set) by Types (2012-2017) Figure United States Active Pharmaceutical Ingredients (API)? Sales (K Sets) and Growth Rate (%) (2012-2017) Figure United States Active Pharmaceutical Ingredients (API)? Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure United States Finished Dosage Formulations (FDF) Sales (K Sets) and Growth Rate (%) (2012-2017) Figure United States Finished Dosage Formulations (FDF) Revenue (Million USD) and Growth Rate (%) (2012-2017) Table United States Contract Pharmaceutical Manufacturing Sales (K Sets) by Applications (2012-2017) Table United States Contract Pharmaceutical Manufacturing Sales Market Share (%) by Applications (2012-2017) Figure United States Contract Pharmaceutical Manufacturing Sales Market Share (%) by Applications (2012-2017) Figure United States Contract Pharmaceutical Manufacturing Sales Market Share (%) by Applications in 2016 Table United States Contract Pharmaceutical Manufacturing Sales Growth Rate (%) by Applications (2012-2017) Figure United States Contract Pharmaceutical Manufacturing Sales Growth Rate (%) by Applications (2012-2017) Figure United States Big Pharma Sales (K Sets) and Growth Rate (%) (2012-2017) Figure United States Specialty/Midsize Companies Sales (K Sets) and Growth Rate (%) (2012-2017) Figure United States Pharmaceutical Generics Sales (K Sets) and Growth Rate (%) (2012-2017) Table Catalent Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Catalent Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure Catalent Contract Pharmaceutical Manufacturing Sales Growth Rate (%) (2012-2017) Figure Catalent Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure Catalent Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table DPx Basic Information, Manufacturing Base, Sales Area and Its Competitors Table DPx Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure DPx Contract Pharmaceutical Manufacturing Sales Growth Rate (%) (2012-2017) Figure DPx Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure DPx Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table Lonza Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Lonza Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure Lonza Contract Pharmaceutical Manufacturing Sales Growth Rate (%) (2012-2017) Figure Lonza Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure Lonza Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table Piramal Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Piramal Healthcare Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure Piramal Healthcare Contract Pharmaceutical Manufacturing Sales Growth Rate (%) (2012-2017) Figure Piramal Healthcare Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table Aenova Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Aenova Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure Aenova Contract Pharmaceutical Manufacturing Sales Growth Rate (%) (2012-2017) Figure Aenova Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure Aenova Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table Jubilant Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Jubilant Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure Jubilant Contract Pharmaceutical Manufacturing Sales Growth Rate (%) in United States (2012-2017) Figure Jubilant Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure Jubilant Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table Famar Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Famar Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure Famar Contract Pharmaceutical Manufacturing Sales Growth Rate (%) (2012-2017) Figure Famar Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure Famar Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales Growth Rate (%) (2012-2017) Figure Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table Fareva Holding Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Fareva Holding Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure Fareva Holding Contract Pharmaceutical Manufacturing Sales Growth Rate (%) (2012-2017) Figure Fareva Holding Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure Fareva Holding Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table AbbVie? Basic Information, Manufacturing Base, Sales Area and Its Competitors Table AbbVie? Contract Pharmaceutical Manufacturing Sales (K Sets), Revenue (Million USD), Price (USD/Set), Gross Margin (%) and Market Share (%) (2012-2017) Figure AbbVie? Contract Pharmaceutical Manufacturing Sales Growth Rate (%) (2012-2017) Figure AbbVie? Contract Pharmaceutical Manufacturing Sales Market Share (%) in United States (2012-2017) Figure AbbVie? Contract Pharmaceutical Manufacturing Revenue Market Share (%) in United States (2012-2017) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Contract Pharmaceutical Manufacturing Figure Contract Pharmaceutical Manufacturing Industrial Chain Analysis Table Major Buyers of Contract Pharmaceutical Manufacturing Table Distributors/Traders List Figure Global Contract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Forecast (2017-2022) Figure Global Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022) Figure United States Contract Pharmaceutical ManufacturingContract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Forecast (2017-2022) Figure United States Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022) Table Global Contract Pharmaceutical Manufacturing Sales (K Sets) Forecast by Regions (2017-2022) Figure Global Contract Pharmaceutical Manufacturing Sales Market Share (%) Forecast by Regions (2017-2022) Figure North America Contract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Forecast (2017-2022) Figure North America Contract Pharmaceutical Manufacturing Revenue and Growth Rate (%) Forecast (2017-2022) Figure Europe Contract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Forecast (2017-2022) Figure Europe Contract Pharmaceutical Manufacturing Revenue and Growth Rate (%) Forecast (2017-2022) Figure Asia-Pacific Contract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Forecast (2017-2022) Figure Asia-Pacific Contract Pharmaceutical Manufacturing Revenue and Growth Rate (%) Forecast (2017-2022) Figure South America Contract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Forecast (2017-2022) Figure South America Contract Pharmaceutical Manufacturing Revenue and Growth Rate (%) Forecast (2017-2022) Figure Middle East and Africa Contract Pharmaceutical Manufacturing Sales (K Sets) and Growth Rate (%) Forecast (2017-2022) Figure Middle East and Africa Contract Pharmaceutical Manufacturing Revenue and Growth Rate (%) Forecast (2017-2022) Table United Status Contract Pharmaceutical Manufacturing Sales (Million USD) Forecast by Type (2017-2022) Figure United Status Contract Pharmaceutical Manufacturing Sales Market Share (%) Forecast by Type (2017-2022) Table United Status Contract Pharmaceutical Manufacturing Revenue (Million USD) Forecast by Type (2017-2022) Figure United Status Contract Pharmaceutical Manufacturing Revenue Market Share (%) Forecast by Type (2017-2022) Table United Status Contract Pharmaceutical Manufacturing Sales (K Sets) Forecast by Application (2017-2022) Figure United Status Contract Pharmaceutical Manufacturing Sales Forecast by Application (2017-2022)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.